356 related articles for article (PubMed ID: 20018654)
21. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
Vanderpool C; Yan F; Polk DB
Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
[TBL] [Abstract][Full Text] [Related]
22. Probiotic bacteria enhance murine and human intestinal epithelial barrier function.
Madsen K; Cornish A; Soper P; McKaigney C; Jijon H; Yachimec C; Doyle J; Jewell L; De Simone C
Gastroenterology; 2001 Sep; 121(3):580-91. PubMed ID: 11522742
[TBL] [Abstract][Full Text] [Related]
23. Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice.
Weng M; Ganguli K; Zhu W; Shi HN; Walker WA
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G779-87. PubMed ID: 24627567
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory effects of probiotics in the intestinal tract.
Delcenserie V; Martel D; Lamoureux M; Amiot J; Boutin Y; Roy D
Curr Issues Mol Biol; 2008; 10(1-2):37-54. PubMed ID: 18525105
[TBL] [Abstract][Full Text] [Related]
25. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells.
Caballero-Franco C; Keller K; De Simone C; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G315-22. PubMed ID: 16973917
[TBL] [Abstract][Full Text] [Related]
26. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability.
Liu Q; Tian H; Kang Y; Tian Y; Li L; Kang X; Yang H; Wang Y; Tian J; Zhang F; Tong M; Cai H; Fan W
J Nutr Biochem; 2021 Dec; 98():108863. PubMed ID: 34517094
[TBL] [Abstract][Full Text] [Related]
27. Probiotic Pediococcus acidilactici modulates both localised intestinal- and peripheral-immunity in tilapia (Oreochromis niloticus).
Standen BT; Rawling MD; Davies SJ; Castex M; Foey A; Gioacchini G; Carnevali O; Merrifield DL
Fish Shellfish Immunol; 2013 Oct; 35(4):1097-104. PubMed ID: 23871840
[TBL] [Abstract][Full Text] [Related]
28. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius.
O'Hara AM; O'Regan P; Fanning A; O'Mahony C; Macsharry J; Lyons A; Bienenstock J; O'Mahony L; Shanahan F
Immunology; 2006 Jun; 118(2):202-15. PubMed ID: 16771855
[TBL] [Abstract][Full Text] [Related]
29. Probiotic bacteria cell walls stimulate the activity of the intestinal epithelial cells and macrophage functionality.
Lemme-Dumit JM; Polti MA; Perdigón G; Galdeano CM
Benef Microbes; 2018 Jan; 9(1):153-164. PubMed ID: 29124968
[TBL] [Abstract][Full Text] [Related]
30. Beneficial Effects of Probiotic Consumption on the Immune System.
Maldonado Galdeano C; Cazorla SI; Lemme Dumit JM; Vélez E; Perdigón G
Ann Nutr Metab; 2019; 74(2):115-124. PubMed ID: 30673668
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology.
Dinan TG; Cryan JF
Psychoneuroendocrinology; 2012 Sep; 37(9):1369-78. PubMed ID: 22483040
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir.
Romanin D; Serradell M; González Maciel D; Lausada N; Garrote GL; Rumbo M
Int J Food Microbiol; 2010 Jun; 140(2-3):102-8. PubMed ID: 20471126
[TBL] [Abstract][Full Text] [Related]
33. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
Hörmannsperger G; Haller D
Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of action of probiotics.
Walker WA
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S87-91; discussion S144-51. PubMed ID: 18181730
[TBL] [Abstract][Full Text] [Related]
35. Innate immune functions of avian intestinal epithelial cells: Response to bacterial stimuli and localization of responding cells in the developing avian digestive tract.
Bar Shira E; Friedman A
PLoS One; 2018; 13(7):e0200393. PubMed ID: 29979771
[TBL] [Abstract][Full Text] [Related]
36. Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.
Jarry A; Crémet L; Caroff N; Bou-Hanna C; Mussini JM; Reynaud A; Servin AL; Mosnier JF; Liévin-Le Moal V; Laboisse CL
Mucosal Immunol; 2015 May; 8(3):572-81. PubMed ID: 25269707
[TBL] [Abstract][Full Text] [Related]
37. Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes.
Shen X; Liu L; Peek RM; Acra SA; Moore DJ; Wilson KT; He F; Polk DB; Yan F
Mucosal Immunol; 2018 Sep; 11(5):1316-1328. PubMed ID: 29875401
[TBL] [Abstract][Full Text] [Related]
38. VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.
Krishnan M; Penrose HM; Shah NN; Marchelletta RR; McCole DF
Inflamm Bowel Dis; 2016 Dec; 22(12):2811-2823. PubMed ID: 27824650
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal epithelial innate immunity-regionalization and organoids as new model.
Kayisoglu Ö; Schlegel N; Bartfeld S
J Mol Med (Berl); 2021 Apr; 99(4):517-530. PubMed ID: 33538854
[TBL] [Abstract][Full Text] [Related]
40. Exercise, intestinal barrier dysfunction and probiotic supplementation.
Lamprecht M; Frauwallner A
Med Sport Sci; 2012; 59():47-56. PubMed ID: 23075554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
